Cannabis Bioscience International Holdings, Inc. (CBIH) Current Deferred Revenue (2023 - 2025)
Cannabis Bioscience International Holdings (CBIH) posted Current Deferred Revenue of $12000.0 for Q3 2025, down 58.1% sequentially from $28641.0 in Q2 2023.
Cannabis Bioscience International Holdings, Inc. (CBIH) Current Deferred Revenue (2023 - 2025) Analysis & Trends
Cannabis Bioscience International Holdings has reported Current Deferred Revenue for 2 years, with the latest figure at $12000.0 in Q3 2025.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $12000.0 in Q3 2025, while the trailing twelve-month figure through Aug 2025 was $12000.0 (changed N/A YoY) and the FY2023 annual result came in at $28641.0, changed N/A from the prior year.
- Current Deferred Revenue retreated to $12000.0 in Q3 2025 per CBIH's latest filing, from $28641.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $28641.0 in Q2 2023 and troughed at $12000.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2025 | 12,000.00 |
| May 31, 2023 | 28,641.00 |